Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 26, 2021	Sep. 27, 2020	Sep. 26, 2021	Sep. 27, 2020
Net sales	$ 159,673	$ 133,307	$ 513,046	$ 365,760
Cost of goods sold	94,475	77,778	300,969	212,070
Gross profit	65,198	55,529	212,077	153,690
Selling, general, and administrative	28,891	17,303	79,093	48,790
Research and development costs	7,133	5,982	20,167	17,198
Amortization of intangible assets	3,553	2,699	10,391	8,099
Acquisition and restructuring costs	368	1,092	21,877	5,624
Related party acquisition and management fee costs	23,250	894	25,789	2,665
Other operating expense (income)	89	(821)	3	(1,089)
Total operating expense	63,284	27,149	157,320	81,287
Operating income	1,914	28,380	54,757	72,403
Change in fair value of warrant liability	17,273		17,273
Change in fair value of earn-out liability	6,866		6,866
Loss on early extinguishment of debt	1,425		1,425
Interest expense	9,851	9,325	31,096	31,843
Total non-operating expense	35,415	9,325	56,660	31,843
Income (loss) before income taxes	(33,501)	19,055	(1,903)	40,560
Income tax expense	(3,301)	5,512	7,255	9,656
Net income (loss)	(30,200)	13,543	(9,158)	30,904
Comprehensive income (loss)
Foreign currency translation adjustment	(31)		(12)
Total comprehensive income (loss)	$ (30,231)	$ 13,543	$ (9,170)	$ 30,904
Weighted average common shares assuming dilution	106,285,072	67,673,884	80,735,661	67,673,884
Basic net income (loss) per share	$ (0.28)	$ 0.20	$ (0.11)	$ 0.46
Diluted net income (loss) per share	$ (0.28)	$ 0.20	$ (0.11)	$ 0.46